In countries like Iraq, ongoing systemic barriers, ranging from economic instability and limited healthcare infrastructure to regional conflict and disrupted insulin supply chains, compound the difficulties of managing chronic conditions like diabetes [5,6]. Here, INS is linked to diabetes mellitus.